Pathogenesis of Herpetic Stromal Keratitis in CCR5- and/or CXCR3-Deficient Mice

Purpose: Herpetic stromal keratitis (HSK) is an immunopathological reaction to herpes simplex virus type 1 (HSV-1) corneal infection. It has been reported that CD4+ cells play the most important role in the pathogenesis of this disease. In this study, we have focused on two chemokine receptors, CCR5 and CXCR3, which are expressed on CD4+ Th1 cells in mice HSK model. Methods: CCR5-deficient (CCR5KO), CXCR3-deficient (CXCR3KO), CCR5/CXCR3 double-deficient (DKO), and wild type (WT) mice (C57/BL6 background) were infected intracorneally with HSV-1 (CHR3 strain). The corneas were examined biomicroscopically, and cryosections of the corneas were examined histologically and immunohistochemically. Real-time RT-PCR and RNase protection assay (RPA) were performed, and the virus titers were measured in excised eyes and trigeminal ganglia (TG). Results: The HSK clinical severity in DKO mice was significantly lower than that in WT mice, and this was reversed by transfer of cells from the spleen of WT mice to DKO mice. Histologically, the numbers of T cells (CD4+ and CD8+ cells) and neutrophils infiltrating the cornea were significantly fewer in CCR5KO, CXCR3KO, and DKO mice. Transcript levels of immune-related cell surface marker in the eye by RPA were reduced in DKO mice. The expression of I-TAC was significantly increased in the cornea of CCR5KO mice, and MIP-1α and MIP-1β were significantly lower in CXCR3KO mice than in WT mice by RT-PCR. There were no significant differences of virus titers in the eye and TG among any groups of mice except the increase in the TG of DKO mice on day 5 PI. Conclusions: The suppression of chemotaxis and activation of CD4+ Th1 cells by the lacking of CXCR3 and CCR5 causes a decrease of other infiltrating cells, resulting in a lower severity of HSK. These results suggest that targeting chemokine receptors is a promising way to treat HSK.

[1]  J. Ash,et al.  Abnormal immune response of CCR5-deficient mice to ocular infection with herpes simplex virus type 1. , 2006, The Journal of general virology.

[2]  K. Matsushima,et al.  CCR5-deficient mice develop experimental autoimmune uveoretinitis in the context of a deviant effector response. , 2005, Investigative ophthalmology & visual science.

[3]  J. Ash,et al.  Chemokine receptor deficiency is associated with increased chemokine expression in the peripheral and central nervous systems and increased resistance to herpetic encephalitis , 2005, Journal of Neuroimmunology.

[4]  B. Rouse,et al.  Early events in HSV keratitis--setting the stage for a blinding disease. , 2005, Microbes and infection.

[5]  A. Mates,et al.  CXCR3, IP-10, and Mig are required for CD4+ T cell recruitment during the DTH response to HSV-1 yet are independent of the mechanism for viral clearance. , 2005, Virology.

[6]  D. Coen,et al.  Persistent expression of chemokine and chemokine receptor RNAs at primary and latent sites of herpes simplex virus 1 infection , 2004, Virology Journal.

[7]  Y. Shimomura,et al.  Corneal epithelial cells and stromal keratocytes efficently produce CC chemokine-ligand 20 (CCL20) and attract cells expressing its receptor CCR6 in mouse herpetic stromal keratitis , 2004, Current eye research.

[8]  P. Lundberg,et al.  A potential role for CXCR3 chemokines in the response to ocular HSV infection , 2003, Current eye research.

[9]  B. Rouse,et al.  Mechanisms of pathogenesis in herpetic immunoinflammatory ocular lesions. , 2002, Veterinary microbiology.

[10]  J. Natvig,et al.  Association of Antigen Specificity and Migratory Capacity of Memory T Cells in Rheumatoid Arthritis , 2002, Scandinavian journal of immunology.

[11]  W. Hancock,et al.  Beneficial effects of targeting CCR5 in allograft recipients. , 2001, Transplantation.

[12]  J. Flier,et al.  Differential expression of CXCR3 targeting chemokines CXCL10, CXCL9, and CXCL11 in different types of skin inflammation , 2001, The Journal of pathology.

[13]  Y. Tano,et al.  Preventive effect of local plasmid DNA vaccine encoding gD or gD-IL-2 on herpetic keratitis. , 2000, Investigative ophthalmology & visual science.

[14]  H. Kanegane,et al.  CD30 expression on circulating memory CD4+ T cells as a Th2‐dominated situation in patients with atopic dermatitis , 2000, Allergy.

[15]  C. Mackay,et al.  T-cell function and migration. Two sides of the same coin. , 2000, The New England journal of medicine.

[16]  A. Zlotnik,et al.  Chemokines: a new classification system and their role in immunity. , 2000, Immunity.

[17]  D. Dorfman,et al.  The chemokine receptor CXCR3 is expressed in a subset of B-cell lymphomas and is a marker of B-cell chronic lymphocytic leukemia. , 2000, Blood.

[18]  Y. Tano,et al.  T-cell-mediated immune responses in alloepithelial rejection after murine keratoepithelioplasty. , 1999, Investigative ophthalmology & visual science.

[19]  P. Allavena,et al.  The role of chemokines in the regulation of dendritic cell trafficking , 1999, Journal of leukocyte biology.

[20]  A. Heiligenhaus,et al.  CD4+ T-cell type 1 and type 2 cytokines in the HSV-1 infected cornea , 1999, Graefe's Archive for Clinical and Experimental Ophthalmology.

[21]  A. Richmond,et al.  Multiple chemotactic factors: fine control or redundancy? , 1999, Trends in pharmacological sciences.

[22]  K. Okumura,et al.  Selective accumulation of CCR5+ T lymphocytes into inflamed joints of rheumatoid arthritis. , 1999, International immunology.

[23]  A. Zlotnik,et al.  T-cell subsets: Chemokine receptors guide the way , 1998, Current Biology.

[24]  T. Tumpey,et al.  Absence of Macrophage Inflammatory Protein-1α Prevents the Development of Blinding Herpes Stromal Keratitis , 1998, Journal of Virology.

[25]  C. Mackay,et al.  Flexible Programs of Chemokine Receptor Expression on Human Polarized T Helper 1 and 2 Lymphocytes , 1998, The Journal of experimental medicine.

[26]  C. Mackay,et al.  The chemokine receptors CXCR3 and CCR5 mark subsets of T cells associated with certain inflammatory reactions. , 1998, The Journal of clinical investigation.

[27]  P. Allavena,et al.  Differential Expression of Chemokine Receptors and Chemotactic Responsiveness of Type 1 T Helper Cells (Th1s) and Th2s , 1998, The Journal of experimental medicine.

[28]  C. Mackay,et al.  The HIV coreceptors CXCR4 and CCR5 are differentially expressed and regulated on human T lymphocytes. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[29]  B. Rouse,et al.  On the essential involvement of neutrophils in the immunopathologic disease: herpetic stromal keratitis. , 1997, Journal of immunology.

[30]  J. Oakes,et al.  Protective antibody therapy is associated with reduced chemokine transcripts in herpes simplex virus type 1 corneal infection , 1996, Journal of virology.

[31]  J. Pepose,et al.  Corneal Langerhans cell dynamics after herpes simplex virus reactivation. , 1993, Investigative ophthalmology & visual science.

[32]  D. Taub,et al.  Preferential migration of activated CD4+ and CD8+ T cells in response to MIP-1 alpha and MIP-1 beta , 1993, Science.

[33]  B. Rouse,et al.  Herpetic stromal keratitis: an immunopathologic disease mediated by CD4+ T lymphocytes. , 1992, Investigative ophthalmology & visual science.

[34]  T. Tumpey,et al.  Critical role of corneal Langerhans cells in the CD4- but not CD8-mediated immunopathology in herpes simplex virus-1-infected mouse corneas. , 1992, Journal of immunology.

[35]  J. Convit,et al.  Differing lymphokine profiles of functional subsets of human CD4 and CD8 T cell clones. , 1991, Science.

[36]  Roberta,et al.  Purified protein derivative of Mycobacterium tuberculosis and excretory-secretory antigen(s) of Toxocara canis expand in vitro human T cells with stable and opposite (type 1 T helper or type 2 T helper) profile of cytokine production. , 1991, The Journal of clinical investigation.

[37]  D. Goeddel,et al.  Selective attraction of monocytes and T lymphocytes of the memory phenotype by cytokine RANTES , 1990, Nature.

[38]  T. Mosmann,et al.  Heterogeneity of mouse helper T cells. Evidence from bulk cultures and limiting dilution cloning for precursors of Th1 and Th2 cells. , 1990, Journal of immunology.

[39]  B. Rouse,et al.  Herpes simplex virus-induced stromal keratitis: role of T-lymphocyte subsets in immunopathology , 1989, Journal of virology.

[40]  D. Easty,et al.  Quantitative studies on Langerhans cells in mouse corneal epithelium following infection with herpes simplex virus. , 1987, Experimental eye research.

[41]  R. Coffman,et al.  Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. , 1986, Journal of immunology.

[42]  B. Roizman,et al.  Proteins Specified by Herpes Simplex Virus V. Purification and Structural Proteins of the Herpesvirion , 1972, Journal of virology.

[43]  H. Nomiyama,et al.  Chemokines in immunity. , 2001, Advances in immunology.

[44]  B. Rouse,et al.  Chemokines and ocular pathology caused by corneal infection with herpes simplex virus. , 1999, Journal of neurovirology.

[45]  K. Matsushima,et al.  Selective recruitment of CCR4-bearing Th2 cells toward antigen-presenting cells by the CC chemokines thymus and activation-regulated chemokine and macrophage-derived chemokine. , 1999, International immunology.

[46]  B. Rouse,et al.  Immunopathogenesis of herpetic ocular disease , 1997, Immunologic research.